Actively Recruiting
Comparison of Transcutaneous and Arterial Carbon Dioxide Monitoring During Jet Ventilation in Patients Undergoing Percutaneous Liver Tumour Radiofrequency Ablation
Led by Sahlgrenska University Hospital · Updated on 2025-10-08
100
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are comparing two methods of monitoring carbon dioxide levels during jet ventilation in patients undergoing percutaneous liver tumour radiofrequency ablation. Jet ventilation is used to reduce diaphragm movement during the procedure, improving conditions for the radiologist and reducing risk to surrounding tissue. Since standard end-tidal CO2 monitoring is not possible with jet ventilation, this study evaluates transcutaneous (through the skin) monitoring against arterial blood sampling to determine any differences between the two methods. Participants will receive the usual preoperative care and jet ventilation as per standard protocols. The study involves collecting data on carbon dioxide levels using both transcutaneous and arterial blood gas monitoring methods during the procedure. The data will be analyzed prospectively to assess discrepancies between the two monitoring techniques. Patients will contribute data during their routine care without any additional interventions. Researchers will measure the difference in carbon dioxide levels between the two methods during perioperative management. All patients will be monitored as usual, and the study will track data to analyze the accuracy and reliability of each monitoring method. Participation involves no change to standard treatment and will last only for the duration of the procedure and immediate perioperative period.
CONDITIONS
Brief Title
Comparison of Transcutaneous and Arterial Carbon Dioxide Sampling During Jet Ventilation, a Prospective. Study on Patients Undergoing Percutaneous Liver Tumour Radiofrequency Ablation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients undergoing percutaneous radiofrequency liver tumour ablation requiring jet ventilation
You will not qualify if you...
- Any disease or condition that is not compatible with jet ventilation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Perioperative period
Participants undergoing percutaneous liver tumour radiofrequency ablation with jet ventilation have transcutaneous and arterial carbon dioxide levels monitored during the procedure.
1 procedure visit (in-person)
Trial Site Locations
Total: 1 location
1
Sahlgrenska University Hospital
Gothenburg, Sweden
Actively Recruiting
Research Team
F
Fredrik Olsen, MD PhD
C
Carl Hallgren, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here